Learn why hepatitis B can reactivate during cancer treatment, which therapies increase the risk and how antiviral medicines can help protect liver health.
|Videos|January 31, 2023
Aimee's Dad
Listen
0:00 / 0:00
Aimee shares how "GO2 very positively impacted" her father's lung cancer journey.
Advertisement
Aimee shares how "GO2 very positively impacted" her father's lung cancer journey. " Hear more from Aimee about the important role GO2 played in her father's and she encourages anyone living with and/or impacted by lung cancer to turn to GO2 for the resources they need.
Advertisement
Related to this article
After her sister’s Hodgkin lymphoma diagnosis, remission and relapse, a caregiver reflects on follow-up care, guilt and finding hope between cancer battles.
After a pancreatic cancer diagnosis upended his life and career, one survivor reflects on treatment, resilience and finding hope more than a decade later.
The American Society of Hematology published 2026 guidelines for adults with myelofibrosis on Oct. 14, 2026, with 10 recommendations on genetic testing, JAK inhibitors, anemia, transplant referral and aspirin.
A study found that sentinel lymph node biopsy rarely missed remaining cancer in patients with locally advanced breast cancer whose lymph nodes responded to chemotherapy before surgery.
Alternating two long-used bladder treatments cleared cancer in 24 of 25 patients whose disease had returned after BCG, an early study found. A larger trial comparing the approach with BCG alone is now enrolling.
Lower income, later diagnosis and gaps in treatment drove most of the excess deaths among rural patients, according to new research.
The FDA has cleared TumorSight Risk, software that uses a patient's existing breast MRI, pathology and clinical information to estimate the chance that early HR-positive, HER2-negative breast cancer will come back within five and 10 years.
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Jemperli for dMMR Locally Advanced Rectal Cancer
2
New Myelofibrosis Guidelines Back Wider Gene Testing at Diagnosis
3
Gemcitabine Plus BCG Clears Bladder Cancer in 96% of Patients After BCG Failure
4
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
5